Circulation. 2023 Jul 4;148(1):74-94. doi: 10.1161/CIR.0000000000001145. Epub 2023 May 8.
Asian American individuals make up the fastest growing racial and ethnic group in the United States. Despite the substantial variability that exists in type 2 diabetes and atherosclerotic cardiovascular disease risk among the different subgroups of Asian Americans, the current literature, when available, often fails to examine these subgroups individually. The purpose of this scientific statement is to summarize the latest disaggregated data, when possible, on Asian American demographics, prevalence, biological mechanisms, genetics, health behaviors, acculturation and lifestyle interventions, pharmacological therapy, complementary alternative interventions, and their impact on type 2 diabetes and atherosclerotic cardiovascular disease. On the basis of available evidence to date, we noted that the prevalences of type 2 diabetes and stroke mortality are higher in all Asian American subgroups compared with non-Hispanic White adults. Data also showed that atherosclerotic cardiovascular disease risk is highest among South Asian and Filipino adults but lowest among Chinese, Japanese, and Korean adults. This scientific statement discusses the biological pathway of type 2 diabetes and the possible role of genetics in type 2 diabetes and atherosclerotic cardiovascular disease among Asian American adults. Challenges to provide evidence-based recommendations included the limited data on Asian American adults in risk prediction models, national surveillance surveys, and clinical trials, leading to significant research disparities in this population. The large disparity within this population is a call for action to the public health and clinical health care community, for whom opportunities for the inclusion of the Asian American subgroups should be a priority. Future studies of atherosclerotic cardiovascular disease risk in Asian American adults need to be adequately powered, to incorporate multiple Asian ancestries, and to include multigenerational cohorts. With advances in epidemiology and data analysis and the availability of larger, representative cohorts, furthering refining the Pooled Cohort Equations, in addition to enhancers, would allow better risk estimation in segments of the population. Last, this scientific statement provides individual- and community-level intervention suggestions for health care professionals who interact with the Asian American population.
亚裔美国人是美国增长最快的种族和族裔群体。尽管 2 型糖尿病和动脉粥样硬化性心血管疾病风险在不同的亚裔美国人亚群中存在很大的可变性,但现有文献在可用时往往未能单独检查这些亚群。本科学声明的目的是总结最新的、可能的关于亚裔美国人人口统计学、患病率、生物学机制、遗传学、健康行为、文化适应和生活方式干预、药物治疗、补充替代干预及其对 2 型糖尿病和动脉粥样硬化性心血管疾病的影响的分类数据。根据迄今为止的可用证据,我们注意到,与非西班牙裔白人成年人相比,所有亚裔美国人亚群的 2 型糖尿病和中风死亡率都更高。数据还表明,南亚和菲律宾裔成年人的动脉粥样硬化性心血管疾病风险最高,而中国、日本和韩国成年人的风险最低。本科学声明讨论了 2 型糖尿病的生物学途径以及遗传学在亚裔美国成年人 2 型糖尿病和动脉粥样硬化性心血管疾病中的可能作用。提供基于证据的建议的挑战包括风险预测模型、国家监测调查和临床试验中关于亚裔美国成年人的数据有限,导致该人群存在显著的研究差距。该人群内部的巨大差异呼吁公共卫生和临床医疗保健界采取行动,将包括亚裔美国人亚群在内的机会作为优先事项。未来需要对亚裔美国成年人的动脉粥样硬化性心血管疾病风险进行充分研究,以纳入多种亚洲血统,并包括多代队列。随着流行病学和数据分析的进步以及更大、更具代表性队列的出现,进一步完善 Pooled Cohort Equations,除了增强剂之外,还可以在人群的某些部分更好地进行风险估计。最后,本科学声明为与亚裔美国人人群互动的医疗保健专业人员提供了个人和社区层面的干预建议。